![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
October 14, 2026
A recap of the NCORP Annual Meeting, a preview of the Fall Group Meeting, and a new project from ARPA-H
October 14, 2026
This clinical trial explores new treatment approaches for lymphoma that has relapsed after remission or is no longer responding to initial treatment
October 14, 2026
Nine early-career investigators will present their cancer research projects; two will be selected to receive awards of distinction
October 14, 2026
This phase 3 clinical trial is comparing two first-line treatments for multiple myeloma patients not having a stem cell transplant
October 14, 2026
The latest findings in breast cancer, lymphoma, precision oncology, and tobacco and alcohol use among people undergoing cancer treatment
October 14, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
September 24, 2026
An update on the NCTN and NCORP grants, organizational changes, and what to expect at the Fall 2026 Group Meeting
September 24, 2026
A new study will test a program that provides education and patient navigators for young adults struggling financially after cancer treatment
September 24, 2026
Learn about key scientific sessions, networking opportunities, and educational programming at the Fall 2026 Group Meeting
September 24, 2026
The latest findings in leukemia, lung cancer and precision oncology
September 24, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
August 31, 2026
Insights on a new breast cancer treatment study, concerns about low uptake of genomic testing, and a preview of the Fall Group Meeting